Business Context and Reporting Period
This Form 8-K Current Report was filed by Ipsidy Inc. (not Authid Inc.) on March 10, 2020, covering events occurring on March 6, 2020. The filing reports the appointment of a new director to the Board of Directors and the execution of related compensation and equity agreements.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on corporate governance changes and executive compensation terms. However, it references specific financial thresholds required for future equity vesting:
- Adjusted EBITDA Target: $10,000,000 annually.
- Revenue Target: $20,000,000 over a 12-month period.
- Valuation Target: $125,000,000 market capitalization or valuation.
- Equity Funding Target: $10,000,000 in gross proceeds from a public offering.
Material Changes
The primary material change is the appointment of Phillip Broenniman as a member of the Board of Directors. This appointment was mandated by the terms of the Company's 15% Senior Secured Convertible Notes, granting note holders the right to nominate a director. Additionally, the Company amended an existing stock option granted to director Phillip Kumnick to accelerate vesting upon a Change of Control.
Guidance, Outlook, and Compensation
While no forward-looking financial guidance is provided, the filing details significant performance-based compensation agreements:
- Director Compensation (Broenniman): Annual equity award valued at $72,000 (vesting over 12 months) plus $5,000 per annum for committee service.
- Restricted Stock Purchase Agreement (Broenniman): Right to acquire 1,500,000 shares at par value. Vesting is contingent upon meeting one of five criteria: Change of Control, achieving $10M Adjusted EBITDA, listing on a national exchange with a $125M valuation, achieving a $125M market cap, or generating $20M in revenue.
- Restricted Stock Purchase Agreement (Kumnick): Right to acquire 1,500,000 shares at par value subject to the same vesting criteria. His existing 3,000,000 share option was amended to vest fully upon a Change of Control.
Risks and Contingencies: The vesting of significant equity grants is contingent on the Company achieving substantial financial milestones (revenue, EBITDA, valuation) or undergoing a Change of Control, indicating a focus on strategic restructuring or growth.
Investor Verification Checklist
- Verify the current status of the 15% Senior Secured Convertible Notes and the identity of the note holders who nominated Mr. Broenniman.
- Confirm the Company's current Adjusted EBITDA and revenue figures to assess the feasibility of the $10M EBITDA and $20M revenue vesting targets.
- Review the full text of the Letter Agreement and Restricted Stock Purchase Agreements (Exhibit 10.1) for detailed vesting schedules and forfeiture conditions.
- Check for any pending Change of Control transactions or merger discussions that could trigger immediate vesting of the 3,000,000 shares granted to Mr. Kumnick.
- Confirm the Company's current market capitalization and listing status to evaluate the $125M valuation threshold.